(Q37600612)

21 August 2017

1 reference

title

High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies (English)

1 reference

21 August 2017

1 reference

Y-L Kwong

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

21 September 2009

1 reference

Bone Marrow Transplantation

21 August 2017

published in

1 reference

21 August 2017

volume

44

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

709-714

1 reference

Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Natural killer-cell malignancies: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Progress in understanding and managing natural killer-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

The new World Health Organization classification of lymphomas: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Selective apoptosis of natural killer-cell tumours by l-asparaginase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

Lethal midline granuloma revisited: nasal T/Natural-killer cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

CD56+ NK lymphomas: clinicopathological features and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.239

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.239

1 reference

21 August 2017

1 reference